Personalizing medicine: strategies for implementing the evaluation of anaplastic lymphoma kinase rearrangement in non-small-cell lung cancer in Portugal

Rev Port Pneumol. 2012 Sep-Oct;18(5):244-6. doi: 10.1016/j.rppneu.2012.04.011. Epub 2012 Jun 29.

[Article in English, Portuguese]

Authors

A Araújo¹, A Coelho, R A de Mello, I Azevedo, M Soares, H Queiroga, E Teixeira, B Parente, F Barata

Affiliation

¹ Serviço de Oncologia Médica, Instituto Português de Oncologia Francisco Gentil, Centro do Porto, Porto, Portugal. amfaraujo@netcabo.pt

PMID: 22748945
DOI: 10.1016/j.rppneu.2012.04.011

No abstract available

Publication types

Multicenter Study

MeSH terms

Adult
Aged
Aged, 80 and over
Anaplastic Lymphoma Kinase
Carcinoma, Non-Small-Cell Lung / genetics*
Carcinoma, Non-Small-Cell Lung / therapy
Female
Gene Rearrangement*
Humans
Lung Neoplasms / genetics*
Lung Neoplasms / therapy
Male
Middle Aged
Portugal
Precision Medicine*
Receptor Protein-Tyrosine Kinases / genetics*
Retrospective Studies
Young Adult

Substances

ALK protein, human
Anaplastic Lymphoma Kinase
Receptor Protein-Tyrosine Kinases